Holland David

Chief Marketing Officer & SVPALIMERA SCIENCES INC (ALIM) · full profile →Form 4 · filed Sep 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
1 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 16, 2024Disposed to issuer(D)188K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 16, 2024Disposed to issuer(D)28K0
Sep 16, 2024Disposed to issuer(D)125K0
Sep 16, 2024Disposed to issuer(D)125K0
Sep 16, 2024Disposed to issuer(D)100K0
Sep 16, 2024Disposed to issuer(D)26K0
Sep 16, 2024Disposed to issuer(D)17K0
Sep 16, 2024Disposed to issuer(D)14K0
Sep 16, 2024Disposed to issuer(D)170K0
Sep 16, 2024Disposed to issuer(D)290K0
Sep 16, 2024Disposed to issuer(D)150K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-101113) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ALIM insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-24-101113"
Ask your agent
Use Arkolith to summarize insider buying and selling at ALIMERA SCIENCES INC
over the last 90 days and cite the filings.